Literature DB >> 7545874

Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.

S Kume1, M Takeya, T Mori, N Araki, H Suzuki, S Horiuchi, T Kodama, Y Miyauchi, K Takahashi.   

Abstract

To elucidate the deposition of advanced glycation end products (AGEs) in aortic atherosclerosis, aortic walls were obtained from 25 autopsy cases and examined immunohistochemically and immunoelectron microscopically with a monoclonal antibody specific for AGEs, 6D12. Among the autopsy cases, atherosclerotic lesions were found in the aortas of 22 cases and were composed of diffuse intimal thickening, fatty streaks, atherosclerotic plaques, and/or complicated lesions. In these cases, intracellular AGE accumulation was demonstrated in the intimal lesions of aortic atherosclerosis in 12 cases. Compared with the diffuse intimal thickening, intracellular AGE accumulation was marked in the fatty streaks and atherosclerotic plaques. Immunohistochemical double staining with 6D12 and monoclonal antibodies for macrophages or muscle actin or a polyclonal antibody for scavenger receptors demonstrated that the AGE accumulation in macrophages or their related foam cells was marked in the diffuse intimal thickening and fatty streak lesions and that almost all macrophages and macrophage-derived foam cells possessed scavenger receptors. Immunoelectron microscopic observation revealed the localization of 6D12-positive reaction in lysosomal lipid vacuoles or electron-dense granules of the foam cells. These results indicate that AGE accumulation occurs in macrophages, smooth muscle cells, and their related foam cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545874      PMCID: PMC1870970     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Methods for phenotyping polarized and locomotor human lymphocytes.

Authors:  I Newman; P C Wilkinson
Journal:  J Immunol Methods       Date:  1992-02-14       Impact factor: 2.303

2.  A new monoclonal antibody, PM-2K, specifically recognizes tissue macrophages but not blood monocytes.

Authors:  M Takeya; T Tsuchiya; Y Shimokawa; K Takahashi
Journal:  J Pathol       Date:  1991-04       Impact factor: 7.996

3.  Monoclonal antibody EBM/11: high cellular specificity for human macrophages.

Authors:  P M Kelly; E Bliss; J A Morton; J Burns; J O McGee
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

Review 4.  Monocyte-macrophage participation in atherogenesis: inflammatory components of pathogenesis.

Authors:  C J Schwartz; A J Valente; E A Sprague; J L Kelley; C A Suenram; D T Graves; M M Rozek; E H Edwards; R Delgado
Journal:  Semin Thromb Hemost       Date:  1986-04       Impact factor: 4.180

5.  Prelesional events in atherogenesis. Colocalization of apolipoprotein B, unesterified cholesterol and extracellular phospholipid liposomes in the aorta of hyperlipidemic rabbit.

Authors:  R Mora; F Lupu; N Simionescu
Journal:  Atherosclerosis       Date:  1987-10       Impact factor: 5.162

6.  Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure.

Authors:  S Horiuchi; N Araki; Y Morino
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

7.  Immunochemical detection of advanced glycosylation end products in vivo.

Authors:  Z Makita; H Vlassara; A Cerami; R Bucala
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

8.  Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit.

Authors:  N Simionescu; E Vasile; F Lupu; G Popescu; M Simionescu
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

9.  Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.

Authors:  E Y Skolnik; Z Yang; Z Makita; S Radoff; M Kirstein; H Vlassara
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.

Authors:  Z Yang; Z Makita; Y Horii; S Brunelle; A Cerami; P Sehajpal; M Suthanthiran; H Vlassara
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  46 in total

1.  Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy.

Authors:  Ricardo Gomes; Marta Sousa Silva; Alexandre Quintas; Carlos Cordeiro; António Freire; Paulino Pereira; Américo Martins; Estela Monteiro; Eduardo Barroso; Ana Ponces Freire
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

2.  Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix.

Authors:  T Mitsuhashi; Y M Li; S Fishbane; H Vlassara
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs.

Authors:  A W Stitt; C He; S Friedman; L Scher; P Rossi; L Ong; H Founds; Y M Li; R Bucala; H Vlassara
Journal:  Mol Med       Date:  1997-09       Impact factor: 6.354

4.  Advanced glycation end product deposits in climatic droplet keratopathy.

Authors:  Y Kaji; R Nagai; S Amano; Y Takazawa; M Fukayama; T Oshika
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

5.  Galectin-3 expression in human atherosclerotic lesions.

Authors:  M Nachtigal; Z Al-Assaad; E P Mayer; K Kim; M Monsigny
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

6.  Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis.

Authors:  T Matsuse; E Ohga; S Teramoto; M Fukayama; R Nagai; S Horiuchi; Y Ouchi
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

Review 7.  Role of the Maillard reaction in diabetes mellitus and diseases of aging.

Authors:  S R Thorpe; J W Baynes
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923

8.  Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells.

Authors:  C B Renard; B Askari; L A Suzuki; F Kramer; K E Bornfeldt
Journal:  Diabetologia       Date:  2003-11-01       Impact factor: 10.122

9.  Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.

Authors:  Richard D Semba; Luigi Ferrucci; Kai Sun; Justine Beck; Mansi Dalal; Ravi Varadhan; Jeremy Walston; Jack M Guralnik; Linda P Fried
Journal:  Aging Clin Exp Res       Date:  2009-04       Impact factor: 3.636

10.  Advanced glycation of type I collagen and fibronectin modifies periodontal cell behavior.

Authors:  Jesse Murillo; Yao Wang; Xiaoping Xu; Robert J Klebe; Zhihua Chen; Gustavo Zardeneta; Sanjay Pal; Margarita Mikhailova; Bjorn Steffensen
Journal:  J Periodontol       Date:  2008-11       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.